AMA issues CPT® Category III codes for Mechanical Scalp Cooling, further facilitating the treatment of chemotherapy-induced hair loss

PAXMAN AB today announces that the American Medical Association (AMA) has issued two (2) separate CPT® codes for the "mechanical scalp cooling". The CPT® Category III codes are: 0662T and 0663T and are effective July 1, 2020.

The two new category lll codes for the Paxman Scalp cooling procedure are:

  1. Scalp cooling, mechanical; initial measurement and calibration of cap. (Report 0662T once per chemotherapy treatment period)
  2. Placement of device, monitoring, and removal of device (List separately in addition to code for primary procedure)
(Use 0663T in conjunction with 96409, 96411, 96413, 96415, 96416, 96417)
(Report 0663T once per chemotherapy session)

The issuance of two Category III CPT Codes by the AMA is a key component to PAXMAN's reimbursement and business strategies. Richard Paxman, CEO of PAXMAN, stated, "As we strive to expand patient access to the Paxman Scalp Cooler, the new CPT codes for mechanical scalp cooling have been a priority for our organization. These CPT codes, combined with the extensive work PAXMAN is doing in the area of reimbursement, will expand patient access and enable oncology facilities to appropriately provide this solution to their patients who would otherwise potentially suffer from the devastating side effect of chemotherapy-induced hair loss. This is, a business catalyst for the company and an important access strategy for the patients we serve."

PAXMAN, the leading global manufacturer and supplier of scalp cooling equipment, offers scalp cooling technology to over 350 of the top community and academic oncology centers the United States.

For a full list of the codes please visit CPT® Category III Codes Long Descriptors (PDF, updated Dec. 30, 2020)

Contacts

Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,500 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North Growth Market. FNCA Sweden AB is the company’s Certified Adviser and can be contacted via info@fnca.se and +46 (0)8 528 003 99.

Attachments

AMA Issues CPT® Category III Codes for Mechanical Scalp Cooling

© Modular Finance, source Nordic Press Releases